Journal of integrative and complementary medicine · 2026
Efficacy of Whole-Body Cryotherapy in Ankylosing Spondylitis: A Systematic Review with Meta-Analysis.
СтатьяСистематический обзорМетаанализНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Saidane Olfa, Bouden Selma, Ben Dhia Siwar, Rouached Leila, Mahmoud Ines, Tekaya Rawdha, Ben Tekaya Aicha, Dziri Chadli, Abdelmoula Leila
Аннотация
INTRODUCTION: Ankylosing spondylitis (AS) is a chronic inflammatory disease characterized by pain, stiffness, and progressive joint deformities. While pharmacological treatments remain the standard approach, adjunct therapies like whole-body cryotherapy (WBC) have gained attention for their potential benefits in reducing pain and inflammation. However, the effectiveness of WBC in AS remains unclear.
METHODS: A systematic search was conducted in PubMed, Scopus, Web of Science, and Embase for studies published up to November 2024. The study followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines and was registered in PROSPERO (CRD42024620792). Primary outcomes included disease activity (Bath Ankylosing Spondylitis Disease Activity Index [BASDAI], Ankylosing Spondylitis Disease Activity Score [ASDAS]) and pain intensity (VAS), while secondary outcomes assessed function (Bath Ankylosing Spondylitis Functional Index [BASFI]) and inflammation (C-reactive protein [CRP]). Effect sizes were calculated using Cohen's d, with heterogeneity evaluated through Cochrane's Q-test and Tau2 variance.
RESULTS: Five studies involving 310 patients met the inclusion criteria. Tau-squared was estimated as zero, indicating a common effect size across studies with no dispersion of true effects. Intervention protocols varied in temperature (-60°C to -10°C) and session duration (80 sec to 3 min). WBC significantly improved BASDAI (p < 0.001), ASDAS (p = 0.015), BASFI (p = 0.006), and VAS pain scores (p = 0.005), demonstrating a strong therapeutic effect. However, no significant impact was observed on CRP levels (p = 0.684).
CONCLUSION: WBC significantly improved pain, function, and disease activity in patients with AS. As a promising nonpharmacological adjunct therapy, further research is needed to optimize protocols and evaluate its tolerance and long-term efficacy.
METHODS: A systematic search was conducted in PubMed, Scopus, Web of Science, and Embase for studies published up to November 2024. The study followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines and was registered in PROSPERO (CRD42024620792). Primary outcomes included disease activity (Bath Ankylosing Spondylitis Disease Activity Index [BASDAI], Ankylosing Spondylitis Disease Activity Score [ASDAS]) and pain intensity (VAS), while secondary outcomes assessed function (Bath Ankylosing Spondylitis Functional Index [BASFI]) and inflammation (C-reactive protein [CRP]). Effect sizes were calculated using Cohen's d, with heterogeneity evaluated through Cochrane's Q-test and Tau2 variance.
RESULTS: Five studies involving 310 patients met the inclusion criteria. Tau-squared was estimated as zero, indicating a common effect size across studies with no dispersion of true effects. Intervention protocols varied in temperature (-60°C to -10°C) and session duration (80 sec to 3 min). WBC significantly improved BASDAI (p < 0.001), ASDAS (p = 0.015), BASFI (p = 0.006), and VAS pain scores (p = 0.005), demonstrating a strong therapeutic effect. However, no significant impact was observed on CRP levels (p = 0.684).
CONCLUSION: WBC significantly improved pain, function, and disease activity in patients with AS. As a promising nonpharmacological adjunct therapy, further research is needed to optimize protocols and evaluate its tolerance and long-term efficacy.